Skip to main navigation Skip to search Skip to main content

A 52-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenace Treatment in Patients with Schizophrennia "ASPIRE OPEN-LABEL" (Aripiprazole Intramuscular Depot Program in Schizophreni

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/09 → 12/31/13

Funding

  • Covance: $98,648.49